PDS Biotechnology Corporation
PDSB
$1.26
$0.021.61%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 12.42% | 20.76% | 14.82% | -4.39% | -5.11% |
| Total Depreciation and Amortization | 4.19% | 8.26% | -24.77% | -8.72% | 16.70% |
| Total Amortization of Deferred Charges | 77.44% | 122.46% | 132.99% | 161.59% | 254.54% |
| Total Other Non-Cash Items | -19.11% | -46.25% | -40.63% | -27.25% | -15.72% |
| Change in Net Operating Assets | -2,787.45% | -169.91% | -176.37% | 294.01% | -104.45% |
| Cash from Operations | -4.14% | -7.78% | -9.56% | 6.59% | -30.83% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -5,254.88% | -18.18% | -60.36% | -152.17% | -- |
| Issuance of Common Stock | 42.18% | 97.24% | 113.38% | 118.48% | 64.23% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 23.28% | 100.97% | -19.19% | -18.09% | -52.24% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 13.84% | 74.12% | -137.84% | -77.29% | -301.22% |